Corbus Pharmaceuticals Holdings (CRBP) Non-Current Assets (2014 - 2025)

Corbus Pharmaceuticals Holdings' Non-Current Assets history runs 12 years deep, the most recent figure standing at $1.2 million for Q4 2025.

• In Q4 2025, Non-Current Assets fell 57.25% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $8.0 million (down 42.34% YoY), while the FY2025 annual figure was $1.2 million, down 57.25% from the prior year.
• Non-Current Assets was $1.2 million for Q4 2025 at Corbus Pharmaceuticals Holdings, down from $1.9 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $9.9 million in Q1 2021 to a low of $1.2 million in Q4 2025.
• Historically, Non-Current Assets has averaged $5.2 million across 5 years, with a median of $5.3 million in 2023.
• The sharpest annual moves came in 2021 and 2025: Non-Current Assets decreased 6.53% in 2021, then slumped 57.25% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $7.5 million in 2021, then fell by 18.53% to $6.1 million in 2022, then slipped by 22.91% to $4.7 million in 2023, then slumped by 38.57% to $2.9 million in 2024, then slumped by 57.25% to $1.2 million in 2025.
• The last three Non-Current Assets figures came in at $1.2 million (Q4 2025), $1.9 million (Q3 2025), and $2.3 million (Q2 2025), per Business Quant data.